CARBOPLATIN Side Effects

7023676-1 | Injection Site Erythema, Injection Site Pain, Injection Site Swelling, Injection Site Vesicles
on Sep 29, 2010 Male patient from UNITED STATES , 56 years of age, weighting 123.5 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: injection site erythema, injection site pain, injection site swelling, injection site vesicles. Carboplatin dosage: 777 Mg Once Iv. During the same period patient was treated with TAXOL (329 Mg Once Iv) (View Taxol Review and Taxol Label ).

7023675-X | Infusion Site Erythema, Infusion Site Irritation
Patient was taking Carboplatin (View Usage). Patient had the following side effects: infusion site erythema, infusion site irritation on Sep 29, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 132.3 lb, . Carboplatin dosage: 570 Mg Once Iv. During the same period patient was treated with PACLITAXEL (352 Mg Once Iv) (View Paclitaxel Review and Paclitaxel Label ).

7023663-3 | Abdominal Pain Upper, Anaemia, Asthenia, Blood Albumin Decreased, Blood Urine Present, Body Temperature Increased, Confusional State, Hypotension, Lethargy
Adverse event was reported on Sep 29, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 190 Mg) . Location: UNITED STATES , weighting 241.5 lb, After Carboplatin was administered, patient had the following side effects: abdominal pain upper, anaemia, asthenia, blood albumin decreased, blood urine present, body temperature increased, confusional state, hypotension, lethargy. During the same period patient was treated with TAXOL (270 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7023621-9 | Dyspnoea, Hypersensitivity, Unresponsive To Stimuli
on Sep 30, 2010 Male patient from UNITED STATES , 55 years of age, weighting 198.0 lb, was diagnosed with lung neoplasm and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypersensitivity, unresponsive to stimuli. Carboplatin dosage: 650 Mg 1 Time Iv. During the same period patient was treated with PALONOSETRON (View Palonosetron Review and Palonosetron Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PEMETREXED (View Pemetrexed Review and Pemetrexed Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ).


7022099-9 | Renal Tubular Necrosis
on Sep 28, 2010 Male patient from UNITED STATES , 75 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). Patient had the following side effects: renal tubular necrosis. Carboplatin dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), NEULASTA (Ongoing.) (View Neulasta Review and Neulasta Label ), FOLIC ACID (Ongoing.) (View Folic Acid Review and Folic Acid Label ), DEXAMETHASONE (Ongoing.) (View Dexamethasone Review and Dexamethasone Label ), PREDNISONE (Ongoing.) (View Prednisone Review and Prednisone Label ), BENADRYL (Ongoing.) (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

7019515-5 | Blood Pressure Immeasurable, Cardio-respiratory Arrest, Dyspnoea, Erythema
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: blood pressure immeasurable, cardio-respiratory arrest, dyspnoea, erythema on Sep 10, 2010 from ITALY Additional patient health information: Female patient , 74 years of age, was diagnosed with ovarian epithelial cancer and. Carboplatin dosage: 510 Mg Milligram(s), Intravenous. During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), (SOLDESAM /00016002/) (View (soldesam /00016002/) Review and (soldesam /00016002/) Label ).

7019512-X | Lung Infiltration, Pulmonary Fibrosis
Adverse event was reported on Aug 12, 2009 by a Male patient taking Carboplatin (View Usage) (Dosage: Intravenous) was diagnosed with testis cancer and. Location: NORWAY , 35 years of age, Patient experienced the following unwanted or unexpected effects: lung infiltration, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with ETOPOSIDE (Intravenous) (View Etoposide Review and Etoposide Label ), CISPLATIN (Stopped During November 2004, Intravenous) (View Cisplatin Review and Cisplatin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BLEOMYCIN SULFATE (Intravenous) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ).

7017824-7 | Catheter Site Discharge, Catheter Site Erythema, Neutrophil Count Decreased, Purulent Discharge, Pyrexia
on Sep 27, 2010 Female patient from UNITED STATES , weighting 129.2 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: catheter site discharge, catheter site erythema, neutrophil count decreased, purulent discharge, pyrexia. Carboplatin dosage: 456 Mg. During the same period patient was treated with TAXOL (271 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7017805-3 | Abdominal Pain Upper, Anaemia, Ascites, Asthenia, Azotaemia, Blood Albumin Decreased, Blood Ph Decreased, Blood Potassium Increased, Blood Pressure Increased
on Sep 27, 2010 Female patient from UNITED STATES , weighting 241.5 lb, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: abdominal pain upper, anaemia, ascites, asthenia, azotaemia, blood albumin decreased, blood ph decreased, blood potassium increased, blood pressure increased. Carboplatin dosage: 190 Mg. During the same period patient was treated with TAXOL (270 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7015996-1 | Anaemia, Asthenia, Dyspnoea, Fatigue
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, dyspnoea, fatigue on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer, pain (What is pain?), vomiting, hypertension, prophylaxis and. Carboplatin dosage: 1df=6auc Every 21 Days Last Dose:5aug10. During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PROMETHAZINE (Form:tabs) (View Promethazine Review and Promethazine Label ), ZOFRAN (View Zofran Review and Zofran Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

7014377-4 | Neutropenia
Adverse event was reported on Sep 24, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 591 Mg) . Location: UNITED STATES , weighting 220.9 lb, Patient had the following side effects: neutropenia. During the same period patient was treated with TAXOL (341 Mg) (View Taxol Review and Taxol Label ).

7013988-X | Febrile Neutropenia, Gastroenteritis, Renal Failure
on Sep 23, 2010 Male patient from UNITED KINGDOM , 70 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: febrile neutropenia, gastroenteritis (What is gastroenteritis?), renal failure. Carboplatin dosage: Ongoing. Patient was hospitalized.

7013599-6 | Chills, Pyrexia
on Sep 15, 2010 Female patient from GREECE , 71 years of age, weighting 213.8 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: chills, pyrexia. Carboplatin dosage: 1 Df/day. During the same period patient was treated with ERBITUX (500 Mg/m2 Per 2 Weeks) (View Erbitux Review and Erbitux Label ).

7012072-9 | Blood Magnesium Decreased, Blood Sodium Decreased, Culture Urine Positive, Laboratory Test Interference, Neutrophil Count Decreased, Platelet Count Decreased, Prothrombin Time Prolonged, Pyrexia, White Blood Cell Count Decreased
Patient was taking Carboplatin (View Usage). Patient had the following side effects: blood magnesium decreased, blood sodium decreased, culture urine positive, laboratory test interference, neutrophil count decreased, platelet count decreased, prothrombin time prolonged, pyrexia, white blood cell count decreased on Sep 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 148.3 lb, . Carboplatin dosage: 387 Mg. During the same period patient was treated with TAXOL (244 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7010829-1 | Abdominal Pain, Constipation, Depression, Nausea
Adverse event was reported on Sep 23, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 658 Mg) . Location: UNITED STATES , weighting 133.2 lb, After Carboplatin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), depression (What is depression?), nausea (What is nausea?). During the same period patient was treated with TAXOL (273 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7010432-3 | Asthenia, Loss Of Consciousness, Nausea, Neutropenia, Pyrexia, Septic Shock
on Sep 14, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with lung neoplasm malignant and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, loss of consciousness, nausea (What is nausea?), neutropenia, pyrexia, septic shock. Carboplatin dosage: ^standard Doses^. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ).

7010231-2 | Condition Aggravated, Interstitial Lung Disease
on Sep 13, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with non-small cell lung cancer stage iiib and was treated with Carboplatin (View Usage). Patient had the following side effects: condition aggravated, interstitial lung disease. Carboplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ).

7007805-1 | Dyspnoea At Rest
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: dyspnoea at rest on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 172.0 lb, was diagnosed with metastases to bone, metastases to central nervous system and. Carboplatin dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

7007796-3 | Hepatitis C
Adverse event was reported on Sep 20, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 46 years of age, weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?). During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), VICODIN (View Vicodin Review and Vicodin Label ).

7007605-2 | Renal Impairment, Vomiting, White Blood Cell Count Decreased
on Sep 06, 2010 Male patient from INDIA , child 7 years of age, was diagnosed with neuroblastoma (What is neuroblastoma?) and was treated with Carboplatin (View Usage). Patient had the following side effects: renal impairment, vomiting, white blood cell count decreased. Carboplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), STEM CELL TRANSPLANT (View Stem Cell Transplant Review and Stem Cell Transplant Label ).

7007171-1 | Brain Oedema, Gastrointestinal Haemorrhage, Renal Failure
on Sep 20, 2010 Female patient from UNITED STATES , 70 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer, mucosal inflammation, diarrhoea, cholecystitis chronic and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: brain oedema, gastrointestinal haemorrhage, renal failure. Carboplatin dosage: Day 1 Of Each 21day Cycle. During the same period patient was treated with PACLITAXEL (Day 1 Of Each 21day Cycle) (View Paclitaxel Review and Paclitaxel Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), IMODIUM (2df=2 Caps) (View Imodium Review and Imodium Label ), DEXTROSE (400ml 11may, 400 15jun2010 (no Units)) (View Dextrose Review and Dextrose Label ), TROMCARDIN (30ml 11may,40ml 15jun2010) (View Tromcardin Review and Tromcardin Label ), PREDNISOLONE SODIUM SUCCINATE INJ (View Prednisolone Sodium Succinate Inj Review and Prednisolone Sodium Succinate Inj Label ). Patient was hospitalized.

7004955-0 | Disseminated Intravascular Coagulation
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with carcinoid tumour, cough, hypersensitivity and. Carboplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), TESSALON (600mg) (View Tessalon Review and Tessalon Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ASTELIN (1 Df:2 Unit Nos) (View Astelin Review and Astelin Label ), BENZONATATE (400mg) (View Benzonatate Review and Benzonatate Label ), FEMTRAN (View Femtran Review and Femtran Label ). Patient was hospitalized.

7003509-X | Blood Creatinine Increased, Blood Urea Increased, Haematotoxicity, Metastases To Central Nervous System, Pancytopenia
Adverse event was reported on Aug 31, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: (240 Mg/m2,on Day 1), (200 Mg/m2,on Day 1 At The Fourth Course)) was diagnosed with small cell lung cancer limited stage and. Location: JAPAN , 77 years of age, Patient had the following side effects: blood creatinine increased, blood urea increased, haematotoxicity, metastases to central nervous system, pancytopenia. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6994618-X | Mucosal Inflammation, Pyrexia
on Sep 16, 2010 Male patient from UNITED STATES , 56 years of age, weighting 173.2 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: mucosal inflammation, pyrexia. Carboplatin dosage: 1.5 Auc/wkly/iv. During the same period patient was treated with TAXOL (30mg/m2/wkly/iv) (View Taxol Review and Taxol Label ), PANITUMUMAB (2.5mg/kg/wkly/iv) (View Panitumumab Review and Panitumumab Label ), ISOSOURCE (View Isosource Review and Isosource Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), MIRACLE MOUTHWASH (View Miracle Mouthwash Review and Miracle Mouthwash Label ), NYSTATIN SWISH AND SWALLOW (View Nystatin Swish And Swallow Review and Nystatin Swish And Swallow Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6992409-7 | Flushing, Oxygen Saturation Decreased, Rash Erythematous
on Sep 03, 2010 Female patient from CANADA , 79 years of age, weighting 113.5 lb, was diagnosed with ovarian cancer and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, oxygen saturation decreased, rash erythematous. Carboplatin dosage: 257mg , Every Three Weeks, Intravenous; 240ml, Every Three Weeks, Intravenous. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), ZOFRAN (View Zofran Review and Zofran Label ), DECADRON (View Decadron Review and Decadron Label ).

6986796-3 | Pancytopenia
Patient was taking Carboplatin (View Usage). Patient had the following side effects: pancytopenia on Sep 01, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with small cell lung cancer limited stage and. Carboplatin dosage: On Day 1. During the same period patient was treated with ETOPOSIDE (On Days 1 And 3) (View Etoposide Review and Etoposide Label ).

6986123-1 | Infusion Related Reaction
Adverse event was reported on Sep 03, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 350 Mg Milligram(s)) was diagnosed with ovarian cancer and. Location: FINLAND , 70 years of age, After Carboplatin was administered, patient had the following side effects: infusion related reaction.

6986090-0 | Disease Recurrence, Gene Mutation, Hepatitis B Dna Increased, Hepatitis B Surface Antigen Positive
on Sep 01, 2010 Male patient from TURKEY , 37 years of age, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence, gene mutation, hepatitis b dna increased, hepatitis b surface antigen positive. Carboplatin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), (IFOSFAMIDE) (View (ifosfamide) Review and (ifosfamide) Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), (VINORELBINE) (View (vinorelbine) Review and (vinorelbine) Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6983419-4 | Catheter Site Discharge, Catheter Site Erythema, Neutrophil Count Decreased, Pyrexia
on Sep 14, 2010 Female patient from UNITED STATES , weighting 129.2 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: catheter site discharge, catheter site erythema, neutrophil count decreased, pyrexia. Carboplatin dosage: 456 Mg. During the same period patient was treated with TAXOL (271 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6983415-7 | Leukopenia, White Blood Cell Count Decreased
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: leukopenia, white blood cell count decreased on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 128.5 lb, . Carboplatin dosage: 3488 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (3894 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (391 Mg) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), TAXOL (1539 Mg) (View Taxol Review and Taxol Label ), COMPAZINE (View Compazine Review and Compazine Label ), DECADRON (View Decadron Review and Decadron Label ), EMEND (View Emend Review and Emend Label ), MAALOX (View Maalox Review and Maalox Label ), NEULASTA (View Neulasta Review and Neulasta Label ).

6979610-3 | Cardiac Failure Congestive, Cardio-respiratory Arrest
Adverse event was reported on Sep 10, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 610 Mg) . Location: UNITED STATES , weighting 32.63 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardio-respiratory arrest. During the same period patient was treated with CYCLOPHOSPHAMIDE (2885 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (28 Mg) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), ETOPOSIDE (480 Mg) (View Etoposide Review and Etoposide Label ), VINCRISTINE SULFATE (2.7 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6979609-7 | Radiation Dysphagia, Radiation Oesophagitis
on Sep 10, 2010 Female patient from UNITED STATES , weighting 58.11 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: radiation dysphagia, radiation oesophagitis. Carboplatin dosage: 110 Mg. During the same period patient was treated with TAXOL (48 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6979596-1 | Feeding Tube Complication
on Sep 10, 2010 Female patient from UNITED STATES , weighting 106.9 lb, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: feeding tube complication. Carboplatin dosage: 399 Mg. During the same period patient was treated with ETOPOSIDE (333 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6979310-X | Leukopenia, Renal Impairment
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, renal impairment on Aug 30, 2010 from INDIA Additional patient health information: Male patient , child 7 years of age, was diagnosed with neuroblastoma (What is neuroblastoma?) and. Carboplatin dosage: 1000 Mg/m2. During the same period patient was treated with ETOPOSIDE (640 Mg/m2 Over 3 Days) (View Etoposide Review and Etoposide Label ), MELPHALAN HYDROCHLORIDE (210 Mg/m2) (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

6975460-2 | Pancytopenia, Renal Impairment
Adverse event was reported on Sep 01, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: Given On Day1 Dose Reduced To 200mg/m2) . Location: JAPAN , 77 years of age, Patient had the following side effects: pancytopenia, renal impairment. During the same period patient was treated with ETOPOSIDE (Day1 And 3 Dose Reduced To 30mg/m2) (View Etoposide Review and Etoposide Label ).

6975455-9 | Renal Impairment, Vomiting, White Blood Cell Disorder
on Sep 02, 2010 Male patient from INDIA , child 7 years of age, was diagnosed with haematopoietic stem cell mobilisation and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: renal impairment, vomiting, white blood cell disorder. Carboplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), GRANULOCYTE CSF (View Granulocyte Csf Review and Granulocyte Csf Label ).

6971899-X | Acne, Body Temperature Increased, Dermatitis Acneiform, Erythema, Neutrophil Count Decreased, Skin Exfoliation, Skin Toxicity
on Sep 08, 2010 Male patient from UNITED STATES , weighting 163.4 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), body temperature increased, dermatitis acneiform, erythema, neutrophil count decreased, skin exfoliation, skin toxicity. Carboplatin dosage: 1441 Mg. During the same period patient was treated with ERBITUX (2633 Mg) (View Erbitux Review and Erbitux Label ), TAXOL (752 Mg) (View Taxol Review and Taxol Label ).

6971892-7 | Chills, Infection, Neutropenia
Patient was taking Carboplatin (View Usage). Patient had the following side effects: chills, infection (What is infection?), neutropenia on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 295.6 lb, . Carboplatin dosage: 593 Mg. During the same period patient was treated with TAXOL (350 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6969627-7 | Acute Respiratory Failure, Anuria, Brain Oedema, Coma, Intestinal Haemorrhage, Renal Failure, Thrombocytopenia
Adverse event was reported on Sep 02, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: Day 1 Of Each 21day Cycle) was diagnosed with non-small cell lung cancer, mucosal inflammation, diarrhoea, cholecystitis chronic and. Location: UNITED STATES , 70 years of age, weighting 165.3 lb, After Carboplatin was administered, patient had the following side effects: acute respiratory failure, anuria, brain oedema, coma, intestinal haemorrhage, renal failure, thrombocytopenia. During the same period patient was treated with PACLITAXEL (Day 1 Of Each 21day Cycle) (View Paclitaxel Review and Paclitaxel Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), IMODIUM (2df=2 Caps) (View Imodium Review and Imodium Label ), DEXTROSE (400ml 11may, 400 15jun2010 (no Units)) (View Dextrose Review and Dextrose Label ), TROMCARDIN (30ml 11may,40ml 15jun2010) (View Tromcardin Review and Tromcardin Label ), PREDNISOLONE SODIUM SUCCINATE INJ (View Prednisolone Sodium Succinate Inj Review and Prednisolone Sodium Succinate Inj Label ), ASCORBIC ACID (11may-11may2010;15-15jun2010) (View Ascorbic Acid Review and Ascorbic Acid Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

6969498-9 | Dermatitis Acneiform, Erythema, Neutrophil Count Decreased, Pyrexia, Skin Exfoliation, Skin Toxicity
on Sep 07, 2010 Male patient from UNITED STATES , weighting 163.4 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis acneiform, erythema, neutrophil count decreased, pyrexia, skin exfoliation, skin toxicity. Carboplatin dosage: 1441 Mg. During the same period patient was treated with ERBITUX (2633 Mg) (View Erbitux Review and Erbitux Label ), TAXOL (752 Mg) (View Taxol Review and Taxol Label ).

6968874-8 | Abdominal Abscess, Abdominal Pain Upper, Ascites, Aspiration, Azotaemia, Blood Albumin Decreased, Blood Ph Decreased, Blood Potassium Increased, Cardiac Arrest
on Sep 03, 2010 Female patient from UNITED STATES , weighting 241.5 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: abdominal abscess, abdominal pain upper, ascites, aspiration, azotaemia, blood albumin decreased, blood ph decreased, blood potassium increased, cardiac arrest (What is cardiac arrest?). Carboplatin dosage: 190 Mg. During the same period patient was treated with TAXOL (270 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6966781-8 | Asthenia, Cardio-respiratory Arrest, Cerebrovascular Accident, Convulsion, Decreased Appetite, Diarrhoea, Gastrointestinal Haemorrhage, Glossitis, Hemiparesis
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: asthenia, cardio-respiratory arrest, cerebrovascular accident, convulsion, decreased appetite, diarrhoea, gastrointestinal haemorrhage, glossitis, hemiparesis on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with non-small cell lung cancer and. Carboplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), CP 751,871 (View Cp-751,871 Review and Cp-751,871 Label ), ECOSPRIN (View Ecosprin Review and Ecosprin Label ), CREMAFFIN (View Cremaffin Review and Cremaffin Label ), IMDUR (View Imdur Review and Imdur Label ), FLAVEDON MR (View Flavedon Mr Review and Flavedon Mr Label ), NUCARNIT (View Nucarnit Review and Nucarnit Label ), DYTOR (View Dytor Review and Dytor Label ). Patient was hospitalized.

6966779-X | Asthenia, Vertigo, Vomiting
Adverse event was reported on Sep 02, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer, increased appetite, prophylaxis of nausea and vomiting, medical diet and. Location: UNITED STATES , 79 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, vertigo, vomiting. During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), CP 751,871 (View Cp-751,871 Review and Cp-751,871 Label ), CYPROHEPTADINE HCL (Syrup) (View Cyproheptadine Hcl Review and Cyproheptadine Hcl Label ), DOMSTAL (View Domstal Review and Domstal Label ), BECOSULES (Syrup) (View Becosules Review and Becosules Label ), ZOFER (Tabs) (View Zofer Review and Zofer Label ), ECO PROT PLUS (2 Table Spoon Full) (View Eco-prot Plus Review and Eco-prot Plus Label ), ZEFRICH POWDER (1 Df=2 Table Spoon Full) (View Zefrich Powder Review and Zefrich Powder Label ). Patient was hospitalized.

6966772-7 | Microangiopathic Haemolytic Anaemia
on Sep 01, 2010 Male patient from UNITED STATES , 57 years of age, weighting 222.7 lb, was diagnosed with non-small cell lung cancer, prophylaxis, hypercholesterolaemia, pain management, anxiety (What is anxiety?) and was treated with Carboplatin (View Usage). Patient had the following side effects: microangiopathic haemolytic anaemia. Carboplatin dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6966760-0 | Dermatomyositis
on Sep 02, 2010 Female patient from UNITED KINGDOM , 71 years of age, weighting 132.3 lb, was diagnosed with ovarian cancer and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: dermatomyositis. Carboplatin dosage: Recent Inf On 30mar10 (duration 106 Days). During the same period patient was treated with PACLITAXEL (Recent Inf On 30mar10 (duration 106 Days)) (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6964051-5 | Abdominal Abscess, Abdominal Pain Upper, Ascites, Asthenia, Azotaemia, Blood Potassium Increased, Cardiac Arrest, Confusional State, Fluid Overload
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal abscess, abdominal pain upper, ascites, asthenia, azotaemia, blood potassium increased, cardiac arrest (What is cardiac arrest?), confusional state, fluid overload on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 241.5 lb, . Carboplatin dosage: 190 Mg. During the same period patient was treated with TAXOL (270 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6962742-3 | Hepatitis C
Adverse event was reported on Aug 31, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 46 years of age, weighting 127.9 lb, Patient had the following side effects: hepatitis c (What is hepatitis c?). During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6962202-X | Chills, Infection, Neutropenia
on Sep 01, 2010 Female patient from UNITED STATES , weighting 295.6 lb, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: chills, infection (What is infection?), neutropenia. Carboplatin dosage: 593 Mg. During the same period patient was treated with TAXOL (350 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6962181-5 | Pyrexia
on Sep 01, 2010 Male patient from UNITED STATES , weighting 163.4 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia. Carboplatin dosage: 724 Mg. During the same period patient was treated with ERBITUX (1229 Mg) (View Erbitux Review and Erbitux Label ), TAXOL (378 Mg) (View Taxol Review and Taxol Label ).

6962180-3 | Fatigue, Mental Status Changes, Pneumonia, Radiation Pneumonitis
Patient was taking Carboplatin (View Usage). Patient had the following side effects: fatigue, mental status changes, pneumonia (What is pneumonia?), radiation pneumonitis on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 159.2 lb, . Carboplatin dosage: 540 Mg. During the same period patient was treated with ERBITUX (440 Mg) (View Erbitux Review and Erbitux Label ), TAXOL (350 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.